2023 ICD-10-CM Diagnosis Code C84.7

Anaplastic large cell lymphoma, ALK-negative

    2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
  • C84.7 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2023 edition of ICD-10-CM C84.7 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of C84.7 - other international versions of ICD-10 C84.7 may differ.
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C84.7. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • primary cutaneous CD30-positive T-cell proliferations (
    ICD-10-CM Diagnosis Code C86.6

    Primary cutaneous CD30-positive T-cell proliferations

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Lymphomatoid papulosis
    • Primary cutaneous anaplastic large cell lymphoma
    • Primary cutaneous CD30-positive large T-cell lymphoma
    C86.6-
    )
The following code(s) above C84.7 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C84.7:
  • C00-D49
    2023 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C81-C96
    2023 ICD-10-CM Range C81-C96

    Malignant neoplasms of lymphoid, hematopoietic and related tissue

    Type 2 Excludes
    • Kaposi's sarcoma of lymph nodes (C46.3)
    • secondary and unspecified neoplasm of lymph nodes (C77.-)
    • secondary neoplasm of bone marrow (C79.52)
    • secondary neoplasm of spleen (C78.89)
    Malignant neoplasms of lymphoid, hematopoietic and related tissue
  • C84
    ICD-10-CM Diagnosis Code C84

    Mature T/NK-cell lymphomas

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • personal history of non-Hodgkin lymphoma (Z85.72)
    Mature T/NK-cell lymphomas
Clinical Information
  • A t-cell peripheral lymphoma morphologically indistinguishable from anaplastic large cell lymphoma, alk-positive. It is characterized by the absence of the translocation involving the alk gene and lacks expression of alk fusion protein.
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to C84.7:
  • Type 1 Excludes: C86
    ICD-10-CM Diagnosis Code C86

    Other specified types of T/NK-cell lymphoma

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • anaplastic large cell lymphoma, ALK negative (C84.7-)
    • anaplastic large cell lymphoma, ALK positive (C84.6-)
    • mature T/NK-cell lymphomas (C84.-)
    • other specified types of non-Hodgkin lymphoma (C85.8-)

Diagnosis Index entries containing back-references to C84.7:
  • Lymphoma (of) (malignant) C85.90
    ICD-10-CM Diagnosis Code C85.90

    Non-Hodgkin lymphoma, unspecified, unspecified site

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code

ICD-10-CM Codes Adjacent To C84.7
C84.60 …… unspecified site
C84.61 …… lymph nodes of head, face, and neck
C84.62 …… intrathoracic lymph nodes
C84.63 …… intra-abdominal lymph nodes
C84.64 …… lymph nodes of axilla and upper limb
C84.65 …… lymph nodes of inguinal region and lower limb
C84.66 …… intrapelvic lymph nodes
C84.67 …… spleen
C84.68 …… lymph nodes of multiple sites
C84.69 …… extranodal and solid organ sites
C84.7 Anaplastic large cell lymphoma, ALK-negative
C84.70 …… unspecified site
C84.71 …… lymph nodes of head, face, and neck
C84.72 …… intrathoracic lymph nodes
C84.73 …… intra-abdominal lymph nodes
C84.74 …… lymph nodes of axilla and upper limb
C84.75 …… lymph nodes of inguinal region and lower limb
C84.76 …… intrapelvic lymph nodes
C84.77 …… spleen
C84.78 …… lymph nodes of multiple sites
C84.79 …… extranodal and solid organ sites

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.